William Blair & Company’s iShares US Pharmaceuticals ETF IHE Stock Holding History

William Blair & Company’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29.7K	Buy	+300	New	+$27K	﹤0.01%	1820
2024 Q4	–	Sell	-52	Closed	-$3.67K	–	1847
2024 Q3	$3.67K	Hold	52	–	–	﹤0.01%	1793
2024 Q2	$3.45K	Buy	+52	New	+$3.41K	﹤0.01%	1791
2023 Q4	–	Sell	-483	Closed	-$28.4K	–	1815
2023 Q3	$28.4K	Hold	483	–	–	﹤0.01%	1647
2023 Q2	$28.8K	Sell	483 -12,312	-96%	-$732K	﹤0.01%	1662
2023 Q1	$748K	Sell	12,795 -384	-3%	-$23.1K	﹤0.01%	914
2022 Q4	$818K	Buy	13,179 +3	+0%	+$180	﹤0.01%	893
2022 Q3	$745K	Buy	13,176 +387	+3%	+$23.8K	﹤0.01%	915
2022 Q2	$817K	Buy	12,789 +11,889	+1,321%	+$755K	﹤0.01%	915
2022 Q1	$58K	Buy	+900	New	+$57.1K	﹤0.01%	1692
2020 Q2	–	Sell	-420	Closed	-$19K	–	1708
2020 Q1	$19K	Hold	420	–	–	﹤0.01%	1497
2019 Q4	$22K	Hold	420	–	–	﹤0.01%	1572
2019 Q3	$20K	Hold	420	–	–	﹤0.01%	1543
2019 Q2	$21K	Hold	420	–	–	﹤0.01%	1578
2019 Q1	$22K	Hold	420	–	–	﹤0.01%	1553
2018 Q4	$21K	Buy	+420	New	+$21.5K	﹤0.01%	1487
2015 Q1	–	Sell	-7,800	Closed	-$393K	–	2170
2014 Q4	$393K	Hold	7,800	–	–	﹤0.01%	1758
2014 Q3	$364K	Hold	7,800	–	–	﹤0.01%	1778
2014 Q2	$351K	Hold	7,800	–	–	﹤0.01%	1766
2014 Q1	$329K	Hold	7,800	–	–	﹤0.01%	1736
2013 Q4	$307K	Hold	7,800	–	–	﹤0.01%	1732
2013 Q3	$276K	Hold	7,800	–	–	﹤0.01%	1758
2013 Q2	$259K	Buy	+7,800	New	+$259K	﹤0.01%	1724

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

William Blair & Company's IHE Position: Q2 2026 in Review

William Blair & Company opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q2 2026: 300 shares worth $29.7K. The stake represents ﹤0.01% of the portfolio and ranks #1820 among its holdings. This is a return to the name: William Blair & Company previously reported a position in IHE as recently as Q3 2024.

William Blair & Company first reported a position in IHE in Q2 2013 and has held it in 23 quarters since. The position peaked at $818K in Q4 2022. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

William Blair & Company held 300 shares of iShares US Pharmaceuticals ETF worth $29.7K as of Q2 2026.
iShares US Pharmaceuticals ETF was a new William Blair & Company position in Q2 2026.
iShares US Pharmaceuticals ETF made up ﹤0.01% of William Blair & Company's portfolio in Q2 2026, its #1820 holding.
William Blair & Company first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 23 quarters since.
William Blair & Company's iShares US Pharmaceuticals ETF position peaked at $818K in Q4 2022.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.